Stockreport

Week In Review: UCB Sells China Drug Portfolio For $680 Million To CBC [Seeking Alpha]

ADC Therapeutics SA Common Shares  (ADCT) 
PDF Summary UCB announced plans to divest its entire current China five-drug portfolio, narrowing its China focus to commercialize soon-to-arrive late-stage clinical asse [Read more]